FDA reverses course, will review Moderna’s flu vaccine
FDA态度逆转，将审查摩德纳流感疫苗

Moderna said that the FDA will review the company’s flu vaccine after all, now that the two sides agreed to an amended filing.
摩德纳表示，在双方就修订后的申报达成一致后，FDA最终将审查该公司的流感疫苗。